Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06444594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transient Receptor Potential Channels

Study acronym: TRP
StatusEnrolling by Invitation
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2025 → Dec 31, 2026
See other at-risk trials from Penn State University

Record History

  1. Primary completion pushed from Dec 31, 2025 to Dec 31, 2026 Trial status changed: Recruiting → Enrolling by Invitation · Completion pushed from Dec 31, 2026 to Dec 31, 2027 · Site details revisedv3 Show 3 more changesShow less
    • Trial status changed: Recruiting → Enrolling by Invitation
    • Completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jun 15, 2024 to Jul 17, 2024 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Jun 15, 2024 to Jul 17, 2024
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Neurovascular signaling in the skin associated with stimulation of the transient receptor potential (TRP) channels. These channels are stimulated by both temperature and naturally occurring bioactive agents found in mint, chili peppers, garlic, etc. The aim of the study is to examine how topically applied TRP channel agonists including menthol, capsaicin and camphor impact neurovascular responses in the skin.
Trial Details
NCT Number NCT06444594
Lead Sponsor Penn State University
Conditions Aging
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov